Open access · CC-BY
via OpenAlex
Choroidal thickness as a biomarker of inflammatory activity in patients with polymyalgia rheumatica receiving anti–IL-6 treatment
Laura Trives-Folguera, Santiago Muñoz‐Fernández, M. D. M. Esteban-Ortega, Javier Leyva-Esteban, Raquel Coca-Serrano, Tatiana Cobo‐Ibáñez, Cristina Vergara-Dangond, Liz Romero-Bogado, Isabel de la Cámara-Fernández, Patricia Richi, María Beatriz Paredes, Ana Esteban, Ana Valeria Acosta-Alfaro, Gabriela Cueva-Nájera, Marco Algarra-San José
Frontiers in Medicine · 2026
Abstract
Objective: In corticosteroid-dependent polymyalgia rheumatica (PMR), anti-interleukin-6 (IL-6) therapies are frequently used; however, they may limit the reliability of acute-phase reactants (APRs) as biomarkers of disease activity. Choroidal thickness (CT) may serve as an alternative inflammatory biomarker in these patients. So, the aim of this study is to evaluate changes in CT in patients with PMR initiating anti-IL-6 therapy over 6 months follow-up period, and to assess its correlation and level of agreement with other inflammatory parameters. Methods: It is a prospective, observational, longitudinal pilot study. We included 24 patients with PMR who initiated anti-IL-6 therapy. Assessments were performed at baseline (treatment initiation), and at 1 and 6 months. Each visit included a physical examination, musculoskeletal ultrasound of the shoulders and hips, blood tests (including C-reactive protein [CRP]), and CT measurement by optical coherence tomography (OCT). Disease activity was assessed using the PMR Activity Score (PMR-AS) and its imputed version (PMR-ASimp). Results: = 0.043). No significant correlations were found between CT and the other assessed parameters. Agreement between changes in CT and CRP was 83.3% at 1 month and 79.1% at 6 months. Agreement between changes in CT and PMR indices was 83.3% at both 1 and 6 months. Conclusion: In patients with active PMR, CT was increased at baseline and decreased significantly following initiation of anti-IL-6 therapy. Agreement between changes in CT and changes in CRP and PMR indices was high. These findings suggest that CT may be useful as a potential inflammatory biomarker in PMR, although further studies are needed to confirm this hypothesis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fmed.2026.1917539
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Trives-Folguera, L., Muñoz‐Fernández, S., Esteban-Ortega, M.D.M., Leyva-Esteban, J., Coca-Serrano, R., Cobo‐Ibáñez, T., Vergara-Dangond, C., Romero-Bogado, L., Cámara-Fernández, I.D.L., Richi, P., Paredes, M.B., Esteban, A., Acosta-Alfaro, A.V., Cueva-Nájera, G., José, M.A., Thuissard–Vasallo, I.J., & Steiner, M. (2026). Choroidal thickness as a biomarker of inflammatory activity in patients with polymyalgia rheumatica receiving anti–IL-6 treatment. <em>Frontiers in Medicine</em>. https://doi.org/10.3389/fmed.2026.1917539
Vancouver
Trives-Folguera L, Muñoz‐Fernández S, Esteban-Ortega MDM, Leyva-Esteban J, Coca-Serrano R, Cobo‐Ibáñez T, et al. Choroidal thickness as a biomarker of inflammatory activity in patients with polymyalgia rheumatica receiving anti–IL-6 treatment. Frontiers in Medicine. 2026. doi:10.3389/fmed.2026.1917539.
BibTeX
@article{laura2026Choroi,
title = {Choroidal thickness as a biomarker of inflammatory activity in patients with polymyalgia rheumatica receiving anti–IL-6 treatment},
author = {Laura Trives-Folguera and Santiago Muñoz‐Fernández and M. D. M. Esteban-Ortega and Javier Leyva-Esteban and Raquel Coca-Serrano and Tatiana Cobo‐Ibáñez and Cristina Vergara-Dangond and Liz Romero-Bogado and Isabel de la Cámara-Fernández and Patricia Richi and María Beatriz Paredes and Ana Esteban and Ana Valeria Acosta-Alfaro and Gabriela Cueva-Nájera and Marco Algarra-San José and Israel John Thuissard–Vasallo and Martina Steiner},
journal = {Frontiers in Medicine},
year = {2026},
doi = {10.3389/fmed.2026.1917539},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Clinical Oncology 2024
Open access · OA
Inflammatory biomarkers and frailty transitions in older adults with cancer: Findings from a national cohort study.
Allergologia et Immunopathologia 2014
Open access · OA
Inflammatory markers in patients with rheumatoid arthritis
Circulation 2015
Citation only
Abstract 14731: Association of Longitudinal Changes in CRP, IL-6, and Fibrinogen Level With Cardiovascular Disease Events: The Multi-Ethnic Study of Atherosclerosis (MESA)
PLoS ONE 2011
Open access · CC-BY
Levels and Determinants of Inflammatory Biomarkers in a Swiss Population-Based Sample (CoLaus Study)
Makara Journal of Health Research 2026
Open access · CC-BY
Physical Activity Intensity and Memory in Middle-Aged and Older Adults in China
Archives of Ophthalmology 2005
Citation only